Abstract
Pharmacogenomics (PGx) refers to how genetic variation can impact response to medications. It has great potential for clinical application as over 350 drugs have FDA approved PGx information in their labeling and 85-95% of the population will have an actionable PGx variant. Given the paucity of information about application and utility of PGx in prenatal testing, we reviewed fetal PGx data and the potential clinical implications in medically-complex neonates.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
